FDA OKs genomic alteration of pigs for human food, possible medical uses

The FDA has approved an intentional genomic alteration process in a line of domestic pigs that is intended to eliminate alpha-gal sugar on the pigs’ cell surfaces.The intentional genomic alteration (IGA), referred to GalSafe pigs (Revivicor), allows the production of pork meat that is free of detectable alpha-gal sugar, a substance that may cause mild or severe allergic reactions in patients with Alpha-gal syndrome, according to the FDA.Potentially, the IGA could help drug developers manufacture therapeutics like heparin with undetectable levels alpha-gal sugar. It may also provideRead More

Share on facebook
Share on twitter
Share on linkedin